Deal Announcements

Pervasis Therapeutics Nets $10 Million Venture Capital

Thursday, September 17, 2009 5:49:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts  --  Biotechnology company Pervasis Therapeutics has garnered $10 million in a new round of venture capital funding.

Pervasis Therapeutics is creating "biologically active vascular technologies to treat significant unmet needs in cardiovascular disease."

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1